Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,360.80 +222.69 1.47%
Hang Seng 23,471.30 +388.65 1.68%
S&P/ASX 200 5,209.00 +28.23 0.54%
  • Fund Type: SICAV
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

BlackRock Global Funds - World Healthscience Fund

+ Add to Watchlist

MEALU:LX

23.4100 USD 0.1400 0.59%

As of 11:19:25 ET on 05/17/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for BlackRock Global Funds - World Healthscience Fund (MEALU)

Open: 23.4100 High - Low: 23.4100 - 23.4100 Primary Exchange: Luxembourg
Volume: 0 52-Week Range: - Beta vs NDWUHC: -

ETF Chart for MEALU

No chart data available.
  • MEALU:LX 23.4100
  • 1M
  • 1Y
23.5500
Interactive MEALU Chart

Previous Close

Fund Profile & Information for MEALU

BlackRock Global Funds - World Healthscience Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to maximize growth in United States dollars. The Fund invests globally in equities of companies with substantial interests in healthcare, pharmaceuticals and medical technology and supplies.

Inception Date: Telephone: 352-34-20-101
Managers: THOMAS P CALLAN
Web Site: www.blackrockinternational.com

Fundamentals for MEALU

NAV -
Assets (M) (on 2013-04-30) 950.9429
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for MEALU

No dividends reported

Performance for MEALU

1-Month - 1-Year -
3-Month - 3-Year -
Year To Date - 5-Year -
Expense Ratio 1.84

Top Fund Holdings for MEALU

Filing Date: 03/28/2013
Name Position Value % of Total
Gilead Sciences Inc 700,386 34,269,887 4.518%
Novartis AG 474,500 33,798,009 4.456%
Johnson & Johnson 412,500 33,631,125 4.434%
Roche Holding AG 129,700 30,269,497 3.991%
Celgene Corp 254,690 29,521,118 3.892%
Amgen Inc 262,700 26,929,377 3.550%
Bristol-Myers Squibb Co 611,900 25,204,161 3.323%
Eli Lilly & Co 398,500 22,630,815 2.984%
Sanofi 221,800 22,577,157 2.976%
AbbVie Inc 486,000 19,819,080 2.613%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil